Show simple item record

dc.contributor.authorFitton, Catherine
dc.contributor.authorFleming, Michael
dc.contributor.authorSteiner, Markus F C
dc.contributor.authorAucott, Lorna
dc.contributor.authorPell, Jill P.
dc.contributor.authorMackay, Daniel F
dc.contributor.authorMcLay, James
dc.date.accessioned2020-04-15T14:30:00Z
dc.date.available2020-04-15T14:30:00Z
dc.date.issued2020-03-01
dc.identifier153509571
dc.identifier9df2dd4a-5412-4c33-88f4-d5e82adbdb20
dc.identifier31884860
dc.identifier000528832000009
dc.identifier85081142342
dc.identifier.citationFitton , C , Fleming , M , Steiner , M F C , Aucott , L , Pell , J P , Mackay , D F & McLay , J 2020 , ' In utero antihypertensive medication exposure and neonatal outcomes : A data linkage cohort study ' , Hypertension , vol. 75 , no. 3 , pp. 628–633 . https://doi.org/10.1161/HYPERTENSIONAHA.119.13802en
dc.identifier.issn0194-911X
dc.identifier.otherORCID: /0000-0001-6277-7972/work/84132150
dc.identifier.otherunpaywall: 10.1161/hypertensionaha.119.13802
dc.identifier.urihttps://hdl.handle.net/2164/14082
dc.descriptionWe acknowledge the support from the Farr Institute @ Scotland. The Farr Institute @ Scotland is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC grant number MR/K007017/1).en
dc.format.extent5
dc.format.extent204548
dc.language.isoeng
dc.relation.ispartofHypertensionen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectantihypertensive agentsen
dc.subjectchilden
dc.subjectgestational ageen
dc.subjecthypertensionen
dc.subjectpregnancyen
dc.subjectDEFECTSen
dc.subjectRISKen
dc.subjectPREGNANCYen
dc.subjectDELIVERYen
dc.subjectLABETALOLen
dc.subjectMAJOR CONGENITAL-MALFORMATIONSen
dc.subjectHYPERTENSIONen
dc.subjectAGEen
dc.subjectR Medicineen
dc.subjectInternal Medicineen
dc.subjectEconomic and Social Research Council (ESRC)en
dc.subjectEngineering and Physical Sciences Research Council (EPSRC)en
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/K007017/1en
dc.subjectCancer Research UKen
dc.subjectChief Scientist Office (CSO)en
dc.subjectMR/K007017/1en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectBritish Heart Foundationen
dc.subjectArthritis Research UK (ARUK)en
dc.subjectWellcome Trusten
dc.subjectMRC Grant No: MR/K007017/1en
dc.subject.lccRen
dc.titleIn utero antihypertensive medication exposure and neonatal outcomes : A data linkage cohort studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Farr Aberdeenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1161/HYPERTENSIONAHA.119.13802
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85081142342&partnerID=8YFLogxKen
dc.identifier.vol75en
dc.identifier.iss3en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record